Publication | Closed Access

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

Neuro-oncologySurgical OncologyRadiation TherapyGastrointestinal OncologyMedicineNeoadjuvant CapecitabineColorectal CancerSurgeryPhase 2Total Mesorectal ExcisionOncologyRadiation OncologyRadiologyHealth Sciences